Their research indicated that the ROS/PI3K/AKT and Wnt/β‐catenin pathways stimulate HIF‐1α‐mediated glucose metabolism, which confers resistance to 5‐FU in CRC [31]. The gene discussed is AKT1; the disease is colorectal carcinoma.